cadenas
  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

ITCC-053 CRISP

A phase IB study of crizotinib (Xalcori®) in pediatric malignancies with anaplastic lymphoma kinase (ALK) aberrations

Promotor Name : Erasmus MC

Investigator Name : M. ZWAAN